Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhanced Recovery Pathway for Endoscopy Patients
NCT04983498Phase 4Withdrawn
- Sponsor
- Northwestern University
- Start
- Sep 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ondansetron, lactated ringer's solution in postoperative nausea and vomiting (PONV), sponsored by Northwestern University. Planned start Sep 2021; status: withdrawn.
02
Drugs
ondansetronlactated ringer's solution
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT04983498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04983498.